ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Recent Research Progress of RGD Peptide-Modified Nanodrug Delivery Systems in Tumor Therapy

Yin, Liyan; Li, Xingchen; Wang, Rongrong; Zeng, Yiying; Zeng, Zhaowu*; Xie, Tian*广东药学院; 杭州师范大学
International Journal of Peptide Research and Therapeutics2023-5-16DOI: 10.1007/s10989-023-10523-4
1被引9阅读
引用收藏
分享

摘要

There have been great advancements in targeted nanodrug delivery systems for tumor therapy. Liposomes, polymeric nanoparticles, and inorganic nanoparticles are commonly employed as nanocarriers for drug delivery, and it has been found that arginine glycine aspartic acid (RGD) peptides and their derivatives can be used as ligands of integrin receptors to enhance the direct targeting ability. In this paper, we review the recent applications of RGD-modified liposomes, polymeric nanoparticles, and inorganic nanocarriers in cancer diagnosis and treatment, discuss the current challenges and prospects, and examine the progress made by the latest research on RGD peptide-modified nano delivery systems in cancer therapy. In recent years, RGD peptide-modified nanodrug delivery systems have been proven to have great potential in tumor therapy. Finally, we provide an overview of the current limitations and future directions of RGD peptide-modified nano-drug delivery systems for cancer therapy. This review aims to elucidate the contribution of RGD peptide-modified nanodrug delivery systems in the field of tumor therapy.

学科与关键词

关键词
CancerIntegrinNanocarrierRGD peptideTargeted drug delivery
相关
加载中…
  • In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles
    Yun, Dan; Liu, Dengyuan; Liu, Jinlin; Feng, Yanyi; Chen, Hongyu; Chen, Simiao; Xie, Qingchun*Pharmaceutics, 2023, 15(11): 2644.
  • iRGD修饰的阿霉素主动靶向脂质体的细胞毒与抗肿瘤效果评价
    赵波; 范俣辰; 王学清; 代文兵; 张强; 王杏林药学学报, 2013, (03): 417-422.
  • NGR多肽修饰的脂质体及其抗肿瘤研究进展
    王咏; 陈军; 林爱华; 方芸中国中药杂志, 2013, (13): 2041-2045.
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Peptide Research and Therapeutics
发表日期
2023-05-16
卷期
第 29 卷, 第 4 期
页码
53
DOI
10.1007/s10989-023-10523-4
语言
ENGLISH
成果收录
SCIE

作者

  • Y

    Yin, Liyan (第一作者)

    guangdong pharmaceut univ · hangzhou normal univ

  • L

    Li, Xingchen

    guangdong pharmaceut univ · hangzhou normal univ

查看全部 6 位作者收起作者
  • W

    Wang, Rongrong

    hangzhou normal univ

  • Z

    Zeng, Yiying

    hangzhou normal univ

  • Z

    Zeng, Zhaowu (通讯)

    hangzhou normal univ

  • X

    Xie, Tian (通讯)

    guangdong pharmaceut univ · hangzhou normal univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417